The Reinhold Cohn Life Science Practice Group is engaged in creating value in intellectual property in the life sciences and chemistry files for inventors, start-ups, academic and medical institutions, and multinational corporations. This ever-evolving industry is particularly challenging given the complexity of biological technologies, long development timelines, regulatory requirements, ethical consideration, patent eligibility requirements by patent offices in different countries and the need for broad geographic protection.
The role of proper patent protection is instrumental in the Life Science industry where partnerships, licensing deals, mergers and acquisitions, that are highly reliant on IP rights, are more prevalent than ever. By creating, securing and maintaining a strong patent portfolio we assist in creating the competitive edge that sets the basis for growth and prosperity of our clients’ businesses. The Reinhold Cohn team is experienced in a broad range of technologies in the life science and healthcare sector such as pharmaceuticals, cannabis tech, health foods, neutraceuticals and food supplements, infant foods and care, medical devices, agriculture, biotechnology, diagnostics and more. We also represent clients in the fast-growing and highly promising healthcare fields such as digital health, computational biology, personalized medicine and advanced genomics.